Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) SHH

65.02

+2.46(+3.93%)

Updated at August 19 03:00PM

Currency In CNY

Valuation

Market Cap5.28B
Enterprise Value4.42B
P/E Ratio51.44
PEG Ratio-2.54
Price/Sales Ratio8.42
Price/Book Ratio4.17
Enterprise/Revenue8.15
Enterprise/EBITDA41.99

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.17
Operating Margin0.16

Management Effectiveness

Return On Assets0.06
Return On Equity0.08

Income Statement

Revenue1.35B
Revenue/Share7.49
Gross Profit1.01B
EBITDA339.11M
Net Income238.23M
Diluted EPS1.36

Balance Sheet

Total Cash1.49B
Total Cash/Share8.38
Total Debt139.35M
Total Debt/Equity0.05
Current Ratio3.37
Book Value Per Share15.5

Price History

52-Week Change92.2
52-Week High68.52
52-Week Low28.85
Moving Average 50 Days48.93
Moving Average 200 Days36.96

Statistics

Average Volume4.67M
Shares Outstanding173.93M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.43
Trailing Annual Dividend Yield0.67
Payout Ratio0.33
Last Split Factor147:100
Last Split DateJuly 01, 2024